LONDON/NEW YORK (Reuters) - Pfizer said on Monday it had abandoned its current attempt to buy AstraZeneca for nearly 70 billion pounds ($118 billion) as a deadline approached without a last-minute change of heart by the British drugmaker. "Following the AstraZeneca board's rejection of the proposal, Pfizer announces that it does not intend to make an offer for AstraZeneca," Pfizer said in a short news release. Pfizer had until 5.00 pm (1200 ET) on May 26 to make a firm offer or walk away, under UK takeover rules. Its decision to quit the stage, at least for now, had been widely expected after AstraZeneca refused its final offer of 55 pounds a share.
via Health News Headlines - Yahoo News http://ift.tt/1tFvEkj
No comments:
Post a Comment